Pacific Biosciences of California, Inc. (PACB)
1.52
-0.04
(-2.56%)
USD |
NASDAQ |
Mar 05, 16:00
1.495
-0.02
(-1.64%)
Pre-Market: 08:10
Pacific Biosciences of California EPS Diluted (Quarterly) : -0.1337 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 2.328 |
| Twist Bioscience Corp. | -0.4995 |
| Boston Scientific Corp. | 0.4493 |
| Intellia Therapeutics, Inc. | -0.8263 |
| Enovis Corp. | -9.074 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.37M |
| Revenue (Quarterly) | 44.64M |
| Total Expenses (Quarterly) | 85.02M |
| Enterprise Value | 881.93M |
| Gross Profit Margin (Quarterly) | 35.24% |
| Profit Margin (Quarterly) | -90.43% |
| Earnings Yield | -120.7% |
| Normalized Earnings Yield | -116.99 |